Literature DB >> 16187116

How septic is urosepsis? Clinical course of infected hydronephrosis and therapeutic strategies.

F Christoph1, S Weikert, M Müller, K Miller, M Schrader.   

Abstract

Despite rapid decompression of the upper urinary tract, some patients show signs of systemic inflammatory response syndrome (SIRS) or septic shock syndrome when infected hydronephrosis is diagnosed. Clinical and biological parameters were analyzed retrospectively in 189 patients diagnosed with hydronephrosis regarding disease severity as well as microbiological and antibiotic features. Fifty of the 189 patients had positive urine culture in the renal pelvis and were included in the study. Fifteen patients had to be placed in the intensive care unit and two patients developed severe septic signs. An initial body temperature above 38.5 degrees C (P=0.0004) and an elevated BMI (P=0.002) were the only parameters that indicated a higher risk of developing SIRS or sepsis. Typical biological parameters were not helpful in differentiating patients who will develop urosepsis. Further research is necessary to provide conclusive evidence of the value of other early prognostic markers in patients with infected hydronephrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187116     DOI: 10.1007/s00345-005-0002-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  14 in total

1.  Goethe almost died of urosepsis.

Authors:  A J Gross; G Hummel
Journal:  World J Urol       Date:  1999-12       Impact factor: 4.226

2.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

3.  Double J stents. A review of 100 patients.

Authors:  R D Pocock; M J Stower; M A Ferro; P J Smith; J C Gingell
Journal:  Br J Urol       Date:  1986-12

Review 4.  Management of pyelonephritis and upper urinary tract infections.

Authors:  J A Roberts
Journal:  Urol Clin North Am       Date:  1999-11       Impact factor: 2.241

5.  A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.

Authors:  J M McCarty; G Richard; W Huck; R M Tucker; R L Tosiello; M Shan; A Heyd; R M Echols
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

6.  Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables.

Authors:  Jean-Luc Reny; Albert Vuagnat; Catherine Ract; Marie-Odile Benoit; Michel Safar; Jean-Yves Fagon
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

7.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Authors:  Evangelos J Giamarellos-Bourboulis; Anna Mega; Paraskevi Grecka; Nektaria Scarpa; George Koratzanis; George Thomopoulos; Helen Giamarellou
Journal:  Intensive Care Med       Date:  2002-08-07       Impact factor: 17.440

8.  The role of C-reactive protein and erythrocyte sedimentation rate in the diagnosis of infected hydronephrosis and pyonephrosis.

Authors:  T T Wu; Y H Lee; W S Tzeng; W C Chen; C C Yu; J K Huang
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

9.  Emergency percutaneous nephrostomy: results and complications.

Authors:  W J Lee; U Patel; S Patel; G P Pillari
Journal:  J Vasc Interv Radiol       Date:  1994 Jan-Feb       Impact factor: 3.464

10.  A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women.

Authors:  G Gossius; L Vorland
Journal:  Scand J Infect Dis       Date:  1984
View more
  4 in total

1.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

2.  Canadian Urological Association guideline: Management of ureteral calculi - Abridged version.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

3.  Canadian Urological Association guideline: Management of ureteral calculi - Full-text.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

4.  Risk factors for treatment failure in renal suppurative infections.

Authors:  Miroslav M Stojadinović; Sava R Mićić; Dragan R Milovanović; Slobodan M Janković
Journal:  Int Urol Nephrol       Date:  2008-08-15       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.